Isobavachalcone inhibits post-entry stages of the porcine reproductive and respiratory syndrome virus life cycle
- 207 Downloads
Porcine reproductive and respiratory syndrome virus (PRRSV) is a pathogen of great economic significance that impacts the swine industry globally. Since the first report of a porcine reproductive and respiratory syndrome (PRRS) outbreak, tremendous efforts to control this disease, including various national policies and plans incorporating the use of multiple modified live-virus vaccines, have been made. However, PRRSV is still a significant threat to the swine industry, and new variants continually emerge as a result of PRRSV evolution. Several studies have shown that pandemic PRRSV strains have enormous genetic diversity and that commercial vaccines can only provide partial protection against these strains. Therefore, effective anti-PRRSV drugs may be more suitable and reliable for PRRSV control. In this study, we observed that isobavachalcone (IBC), which was first isolated from Psoralea corylifolia, had potent anti-PRRSV activity in vitro. Although many biological activities of IBC have been reported, this is the first report describing the antiviral activity of IBC. Furthermore, after a systematic investigation, we demonstrated that IBC inhibits PRRSV replication at the post-entry stage of PRRSV infection. Thus, IBC may be a candidate for further evaluation as a therapeutic agent against PRRSV infection of swine in vivo.
This study was supported by the National Key R&D Program (grant number 2016YFD0500100) and the National Science Foundation of Heilongjiang (grant number ZD2015006).
Y-D Tang and X-H Cai designed the experiments. H-M Wang and other others performed the experiments. All authors analyzed the data. H-M Wang, Y-D Tang and X-H Cai wrote the manuscript.
This study was funded by the National Key R&D Program (grant number 2016YFD0500100) and the National Science Foundation of Heilongjiang (grant number ZD2015006).
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
The experimental protocols for preparing porcine alveolar macrophages (PAMs) were approved by the Animal Care and Protection Committee of Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences.
- 2.Bi Y, Guo XK, Zhao H, Gao L, Wang L, Tang J, Feng WH (2014) Highly pathogenic porcine reproductive and respiratory syndrome virus induces prostaglandin E2 production through cyclooxygenase 1, which is dependent on the ERK1/2-p-C/EBP-beta pathway. J Virol 88:2810–2820CrossRefPubMedPubMedCentralGoogle Scholar
- 4.Cheng J, Sun N, Zhao X, Niu L, Song M, Sun Y, Jiang J, Guo J, Bai Y, He J, Li H (2013) In vitro screening for compounds derived from traditional chinese medicines with antiviral activities against porcine reproductive and respiratory syndrome virus. J Microbiol Biotechnol 23:1076–1083CrossRefPubMedGoogle Scholar
- 21.Renson P, Fablet C, Le Dimna M, Mahe S, Touzain F, Blanchard Y, Paboeuf F, Rose N, Bourry O (2017) Preparation for emergence of an Eastern European porcine reproductive and respiratory syndrome virus (PRRSV) strain in Western Europe: immunization with modified live virus vaccines or a field strain confers partial protection. Vet Microbiol 204:133–140CrossRefPubMedGoogle Scholar
- 28.Tianchao Wei Z, An Tongqing, Zhou Yanjun, YifengJiang Xiaofang Hao, Zhang Shanrui, Peng Jinmei, Qiu Hua-ji, Tong Guang-zhi (2008) Development and application of Taq Man-MGB fluorescence quantitative RT-PCR assay for detection of porcine reproductive and respiratory syndrome virus. Chin J Prev Vet Med 30:6Google Scholar
- 29.Wang G, Yu Y, Zhang C, Tu Y, Tong J, Liu Y, Chang Y, Jiang C, Wang S, Zhou EM, Cai X (2016) Immune responses to modified live virus vaccines developed from classical or highly pathogenic PRRSV following challenge with a highly pathogenic PRRSV strain. Dev Comp Immunol 62:1–7CrossRefPubMedGoogle Scholar
- 33.Wenhui L, Zhongyan W, Guanqun Z, Zhili L, JingYun M, Qingmei X, Baoli S, Yingzuo B (2012) Complete genome sequence of a novel variant porcine reproductive and respiratory syndrome virus (PRRSV) strain: evidence for recombination between vaccine and wild-type PRRSV strains. J Virol 86:9543CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Zhao K, Ye C, Chang XB, Jiang CG, Wang SJ, Cai XH, Tong GZ, Tian ZJ, Shi M, An TQ (2015) Importation and recombination are responsible for the latest emergence of highly pathogenic porcine reproductive and respiratory syndrome virus in China. J Virol 89:10712–10716CrossRefPubMedPubMedCentralGoogle Scholar